雅本化学：2025年全年预计净亏损1.40亿元—1.60亿元

Core Viewpoint - The company, Yabao Chemical, anticipates a significant net loss for the year 2025, with projected losses ranging from 140 million to 160 million RMB, and a net profit loss excluding non-recurring items estimated between 128 million and 148 million RMB [1] Group 1: Financial Performance - The company's pesticide business has shown steady revenue growth; however, increased market competition for key products and ongoing capacity ramp-up for some innovative products have resulted in a low overall gross margin [1] - The pharmaceutical segment has established a partnership with key pharmaceutical clients, but due to the short duration of collaboration, the related research and development and capacity support have not yet positively impacted the company's performance [1] - The company expects to incur a non-recurring loss of approximately 12 million RMB for 2025, primarily due to fair value changes [1] Group 2: Strategic Developments - The company is optimizing the strategic positioning of its pharmaceutical business bases, leading to short-term performance fluctuations due to resource integration and business layout adjustments [1] - The company is deepening its strategic layout for innovative pharmaceuticals and pesticides, which involves necessary and prudent cost investments that may pressure cash flow and profits in the short term but are expected to enhance long-term technical strength and market competitiveness [1] - A subsidiary engaged in bio-waste resource treatment has faced challenges due to industry cycle fluctuations and market competition, leading to a contraction in project scale and an anticipated provision for asset impairment related to accounts receivable [1] Group 3: Impairment and Valuation - The company will conduct impairment testing on goodwill assets in accordance with regulatory requirements, expecting to recognize goodwill impairment [1]